Evaluation of DPA for Treatment of Upper Anterior Crowding
Launched by SAMIA OMAR · Oct 1, 2024
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of clear aligner, called DPA, to help correct crowding in the front teeth of the upper jaw. The goal is to see how effective this aligner is for adults who have mild to moderate crowding of their upper front teeth, which means their teeth are a bit out of place and are overlapping each other.
To be eligible for this study, participants need to be between 18 and 25 years old and should have healthy teeth, with all their adult teeth present except for wisdom teeth. They should not have had any previous orthodontic treatments and must be in good health – meaning no serious diseases, pregnancy, or breastfeeding. If you join this trial, you'll be among the first to try this new aligner and will help researchers learn more about how to improve dental treatments for crowding. The trial is not yet recruiting participants, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult paients .age 18-25y. patients with mild to moderate upper anterior crowding (1mm_6mm)
- • Healthy compliant and motivated patient. full dentition except wisdom teeth.
- Exclusion Criteria:
- • Previous orthodontic treatments. Any systemic disease, pregnancy, or lactating females, with a pocket depth of more than 5mm.
About Samia Omar
Samia Omar is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong focus on ethical practices and regulatory compliance, Samia Omar collaborates with healthcare professionals and research institutions to develop and implement rigorous trial protocols. Their mission is to foster groundbreaking discoveries in healthcare by prioritizing patient safety and data integrity throughout the research process. By leveraging a robust network of experts and resources, Samia Omar aims to bring transformative therapies to market, addressing unmet medical needs across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Al Giza, Egypt
Patients applied
Trial Officials
Sara M .Hosny El kabbany, assistant professor
Principal Investigator
Study Principal Investigator Al azhar universty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported